Lv4
600 积分 2021-08-20 加入
Dual-targeted NAMPT inhibitors as a progressive strategy for cancer therapy
7天前
已完结
NAMPT: A critical driver and therapeutic target for cancer
7天前
已完结
Targeted degradation of extracellular secreted and membrane proteins
14天前
已完结
The Stem Cell Factor Receptor/c-Kit as a Drug Target in Cancer
15天前
已完结
Development and characterization of a fully human antibody targeting SCF/c-kit signaling
15天前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
16天前
已完结
Unveiling the molecular and immunological drivers of antibody–drug conjugates in cancer treatment
24天前
已完结
IgE Neutralization Reverses Trimellitic Anhydride-Induced Urticaria in Humanized CD34+ Mice
25天前
已关闭
Impact of B7-H3 and DLL3 expression on the efficacy of PD-L1 blockade therapy in extensive-stage small cell lung cancer
28天前
已完结
IgE Neutralization Reverses Trimellitic Anhydride-Induced Urticaria in Humanized CD34+ Mice
1个月前
已关闭
皖公网安备34019202002308
